- Home
- LYRA vs WAFU Comparison
LYRA vs WAFU Comparison
Compare LYRA & WAFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- WAFU
- Stock Information
- Founded
- LYRA 2005
- WAFU 1999
- Country
- LYRA United States
- WAFU China
- Employees
- LYRA N/A
- WAFU N/A
- Industry
- LYRA Medical/Dental Instruments
- WAFU Other Consumer Services
- Sector
- LYRA Health Care
- WAFU Real Estate
- Exchange
- LYRA Nasdaq
- WAFU Nasdaq
- Market Cap
- LYRA 7.6M
- WAFU 6.5M
- IPO Year
- LYRA 2020
- WAFU 2019
- Fundamental
- Price
- LYRA $3.88
- WAFU $1.83
- Analyst Decision
- LYRA Hold
- WAFU
- Analyst Count
- LYRA 1
- WAFU 0
- Target Price
- LYRA $16.00
- WAFU N/A
- AVG Volume (30 Days)
- LYRA 30.6K
- WAFU 16.2K
- Earning Date
- LYRA 11-12-2025
- WAFU 01-01-0001
- Dividend Yield
- LYRA N/A
- WAFU N/A
- EPS Growth
- LYRA N/A
- WAFU N/A
- EPS
- LYRA N/A
- WAFU N/A
- Revenue
- LYRA $600,000.00
- WAFU $6,186,645.00
- Revenue This Year
- LYRA N/A
- WAFU N/A
- Revenue Next Year
- LYRA $106.28
- WAFU N/A
- P/E Ratio
- LYRA N/A
- WAFU N/A
- Revenue Growth
- LYRA N/A
- WAFU N/A
- 52 Week Low
- LYRA $3.69
- WAFU $1.22
- 52 Week High
- LYRA $37.50
- WAFU $7.49
- Technical
- Relative Strength Index (RSI)
- LYRA 22.62
- WAFU 54.69
- Support Level
- LYRA $5.40
- WAFU $1.62
- Resistance Level
- LYRA $4.80
- WAFU $1.93
- Average True Range (ATR)
- LYRA 0.42
- WAFU 0.11
- MACD
- LYRA -0.17
- WAFU 0.02
- Stochastic Oscillator
- LYRA 7.39
- WAFU 76.24
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.